Brief: Astrazeneca Pharma India Dec-Quarter PAT 325.9 Million Rupees
11/02/2026 13:32
Feb 11 (Reuters) - Astrazeneca Pharma India Ltd ASTR.NS: ASTRAZENECA PHARMA INDIA DEC-QUARTER PAT 325.9 MILLION RUPEES ASTRAZENECA PHARMA INDIA DEC-QUARTER REVENUE FROM OPERATIONS 6.12 BILLION RUPEES Source text: ID:nBSE5MKvG0 Further company coverage: ASTR.NS ((Reuters.Briefs@thomsonreuters.com;))
Recent news on Astrazeneca Pharma India
See all newsBrief: Astrazeneca Pharma India Receives Permission To Import And Sell Trastuzumab Deruxtecan For Additional Indication
Brief: Astrazeneca Pharma Says Bhavana Agrawal Resigns As CFO
Brief: Astrazeneca Pharma India Receives Permission To Import And Sell Benralizumab For Additional Indication
Brief: Astrazeneca Pharma India Receives Permission To Import Benralizumab (Fasenra) For Additional Indication
Brief: Astrazeneca Pharma Gets Permission To Import For Sale Of Trastuzumab Deruxtecan